XTEMP-E Trademark

Trademark Overview

On Wednesday, July 28, 2021, a trademark application was filed for XTEMP-E with the United States Patent and Trademark Office. The USPTO has given the XTEMP-E trademark a serial number of 90853283. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, September 3, 2024. This trademark is owned by THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.. The XTEMP-E trademark is filed in the Medical Instrument Products category with the following description:

pharmaceuticals dispensing device used to dissolve solid dosage forms in liquid form
xtemp-e

General Information

Serial Number90853283
Word MarkXTEMP-E
Filing DateWednesday, July 28, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements

Pseudo MarkX TEMP-E
Goods and Servicespharmaceuticals dispensing device used to dissolve solid dosage forms in liquid form

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, September 26, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTHE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew York, NY 10005
Party NameTHE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10005

Trademark Events

Event DateEvent Description
Saturday, July 31, 2021NEW APPLICATION ENTERED
Sunday, September 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 25, 2022ASSIGNED TO EXAMINER
Monday, April 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022NOTICE OF ALLOWANCE CANCELLED
Monday, October 17, 2022NEW NOA TO ISSUE
Thursday, July 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 27, 2023SOU EXTENSION 1 FILED
Monday, February 27, 2023SOU EXTENSION 1 GRANTED
Monday, February 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 18, 2024SOU EXTENSION 3 FILED
Monday, March 18, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU EXTENSION 2 FILED
Wednesday, September 6, 2023SOU EXTENSION 2 GRANTED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2024SOU EXTENSION 3 GRANTED
Tuesday, September 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU EXTENSION 4 GRANTED
Tuesday, September 3, 2024SOU EXTENSION 4 FILED
Tuesday, March 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

xtemp dosage forms liquid form solid dissolve dispensing device used pharmaceuticals